Retraction
Published on 28 Sep 2023
Retraction: AnnexinA5 might suppress the phenotype of human gastric cancer cells via ERK pathway
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1294881
- 993 views
Type at least 3 characters
1,724 articles
Articles
Case Report
Published on 27 Sep 2023
Case report: The activity of multi-kinase VEGF inhibitor, Pazopanib, in metastatic undifferentiated round cell sarcomas harboring EWSR1::CREM fusion: clinicopathological series of two cases and literature review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1215003
- 2,320 views
- 3 citations
Original Research
Published on 25 Sep 2023
Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1253659
- 3,672 views
- 1 citation
Systematic Review
Published on 25 Sep 2023
The efficacy and safety of different systemic combination therapies on advanced hepatocellular carcinoma: a systematic review and meta-analysis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1197782
- 1,695 views
Original Research
Published on 25 Sep 2023
Revolutionizing anti-cancer drug discovery against breast cancer and lung cancer by modification of natural genistein: an advanced computational and drug design approach
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1228865
- 4,015 views
- 10 citations
Original Research
Published on 22 Sep 2023
Development, quality, and influencing factors of colonoscopy in China: results from the national census in 2013 and 2020
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1276520
- 2,067 views
- 3 citations
Case Report
Published on 19 Sep 2023
The novel EGFR mutations (p.E746_S752delinsI, p.T751_I759delinsG, p.L747_S752delinsAA) in patients with non-small cell lung cancer and the clinical treatment strategy: three case reports
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1129629
- 2,062 views
- 1 citation
Mini Review
Published on 15 Sep 2023
Beyond liver cancer, more application scenarios for alpha-fetoprotein in clinical practice
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1231420
- 1,576 views
- 1 citation
Original Research
Published on 14 Sep 2023
LTe2 induces cell apoptosis in multiple myeloma by suppressing AKT phosphorylation at Thr308 and Ser473
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1269670
- 1,246 views
Hypothesis and Theory
Published on 14 Sep 2023
Opioids and immune checkpoint inhibitors differentially regulate a common immune network in triple-negative breast cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1267532
- 1,721 views
Original Research
Published on 13 Sep 2023
System analysis based on the lysosome-related genes identifies HPS4 as a novel therapy target for liver hepatocellular carcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1221498
- 1,435 views
- 1 citation
Review
Published on 12 Sep 2023
Cellular senescence: a double-edged sword in cancer therapy
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1189015
- 8,236 views
- 11 citations
Review
Published on 08 Sep 2023
Single domain Camelid antibody fragments for molecular imaging and therapy of cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1257175
- 2,767 views
- 2 citations
Original Research
Published on 08 Sep 2023
Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1238883
- 2,467 views
- 2 citations
Original Research
Published on 07 Sep 2023
CAR requires Gadd45β to promote phenobarbital-induced mouse liver tumors in early stage
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1217847
- 1,453 views
- 2 citations
Original Research
Published on 06 Sep 2023
Pan-cancer analysis identified OAS1 as a potential prognostic biomarker for multiple tumor types
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1207081
- 2,413 views
- 2 citations